Suchergebnisse - "Head and neck neoplasms"

PubPharm (5.346)

1

Cetuximab chemotherapy resistance : Insight into the homeostatic evolution of head and neck cancer (Review)

enthalten in: Oncology reports | 2024

von Diniz, C. | Henrique, T. | Stefanini, A. | +2

2

Science mapping analysis of maxillofacial reconstruction over the last four decades

enthalten in: Journal of stomatology, oral and maxillofacial surgery | 2024

von Grillo, R. | Balel, Y. | Brozoski, M. | +3

3

Mutational landscape of oral mucosal melanoma based on comprehensive cancer genomic profiling tests in a Japanese cohort

enthalten in: Oral oncology | 2024

von Ichimura, N. | Urata, Y. | Kobayashi, T. | +1

4

Efficacy and Safety of Cell-based Immunotherapy in The Treatment of Recurrent or Metastatic Nasopharyngeal Carcinoma - A Systematic Review and Meta-analysis

enthalten in: Oral oncology | 2024

von Yeo, B. | Lee, R. | Lim, N. | +4

5

Stereotactic Body Radiation Therapy Using HyperArc in Treating Patients With Recurrent Head and Neck Cancer : A Phase II Study of Non-Coplanar SBRT Re-Irradiation Using HyperArc in Patients With Recurrent Head and Neck Cancer

enthalten in: ClinicalTrials.gov | 2024

6

Perioperative Nutritional Optimization in Head and Neck Cancer Patients : Perioperative Nutritional Optimization in Head and Neck Cancer Patients

enthalten in: ClinicalTrials.gov | 2024

7

Atorvastatin to Reduce Cisplatin-Induced Hearing Loss Among Individuals With Head and Neck Cancer : Phase II Interventional Study Using Atorvastatin to Reduce Cisplatin-Induced Hearing Loss Among Individuals With Head and Neck Cancer

enthalten in: ClinicalTrials.gov | 2024

8

A Safety, Tolerability and Efficacy Study of NC410 Plus Pembrolizumab in Participants With Advanced Unresectable or Metastatic Solid Tumors : A Phase 1b/2, Open-Label, Safety, Tolerability and Efficacy Study of NC410 Plus Pembrolizumab for Participants With Advanced Unresectable and/or Metastatic Immune Checkpoint Inhibitor (ICI) Refractory Solid Tumors or ICI Naïve MSS/MSI-Low Solid Tumors

enthalten in: ClinicalTrials.gov | 2024

9

TransCon (TC) TLR7/8 Agonist, TC IL-2 β/γ, Pembrolizumab Prior to Surgery for Advanced Head and Neck Squamous Cell Carcinoma : BelieveIT-201: Phase 2, Randomized Open-labeled Trial of TransCon (TC) TLR7/8 Agonist in Combination With Pembrolizumab or With TC IL-2 β/γ, or Pembrolizumab Alone as Neoadjuvant Therapy for Stage III-IVA Resectable Locoregionally Advanced Head and Neck Squamous Cell Carcinoma

enthalten in: ClinicalTrials.gov | 2024

10

Tissue and Hematopoietic/Mesenchymal Stem Cell for Humanized Xenograft Studies in Melanoma and Squamous Head and Neck Cancer : Pilot Study of Tissue and Hematopoietic/Mesenchymal Stem Cell Collection for Humanized Xenograft Studies in Melanoma and Squamous Head and Neck Cancer

enthalten in: ClinicalTrials.gov | 2024

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[535]